Sit Investment Associates’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-329,490
Closed -$5.41M 543
2024
Q2
$5.41M Sell
329,490
-345,595
-51% -$5.56M 0.12% 193
2024
Q1
$11.2M Buy
675,085
+355,762
+111% +$5.51M 0.26% 113
2023
Q4
$4.77M Buy
319,323
+295,550
+1,243% +$4.3M 0.12% 214
2023
Q3
$344K Hold
23,773
0.01% 421
2023
Q2
$363K Hold
23,773
0.01% 442
2023
Q1
$360K Hold
23,773
0.01% 434
2022
Q4
$330K Sell
23,773
-1,464,335
-98% -$20.7M 0.01% 433
2022
Q3
$20.3M Buy
1,488,108
+328,828
+28% +$4.88M 0.61% 38
2022
Q2
$17M Buy
1,159,280
+381,389
+49% +$5.89M 0.52% 49
2022
Q1
$12.9M Buy
777,891
+119,414
+18% +$2.1M 0.35% 88
2021
Q4
$12.8M Buy
+658,477
New +$12.8M 0.3% 98

Other funds holding BCAT

Sit Investment Associates's BCAT Position: Q3 2024 in Review

Sit Investment Associates sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q3 2024, closing a stake of 329,490 shares — an estimated $5.41M sold.

Sit Investment Associates first reported a position in BCAT in Q4 2021 and held it in 11 quarters. The position peaked at $20.3M in Q3 2022. 80 funds tracked by Wall St. Rank hold BCAT as of Q3 2024.

  • Sit Investment Associates reported no remaining BlackRock Capital Allocation Term Trust position as of Q3 2024 after selling out during the quarter.
  • Sit Investment Associates sold 329,490 BlackRock Capital Allocation Term Trust shares in Q3 2024, an estimated $5.41M.
  • Sit Investment Associates first reported a position in BlackRock Capital Allocation Term Trust in Q4 2021 and held it in 11 quarters.
  • Sit Investment Associates's BlackRock Capital Allocation Term Trust position peaked at $20.3M in Q3 2022.
  • 80 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2024.

Based on Sit Investment Associates's 13F filing for Q3 2024, filed 13 Nov 2024.